381,214 matching source rows · Page 917 of 15,249. A security can appear in multiple quarters or reporting entities.
NEUROCRINE BIOSCIENCES INC
COMMON · CUSIP 64125C109
Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617
Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.
- Quarter ended
- 2026-09-30
- Filed
- 2026-11-12
- Reported value (USD)
- $72,229,630
- Reported shares
- 522079
Source units and reporting details
Value as filed: 72229630 USD. Discretion code: DFND. Filing-local manager numbers: 8. Voting authority: sole 479573, shared 22399, none 20107.
Included managers attributed to this row:
- JPMorgan Asset Management (UK) Ltd · 13F file 028-11947
Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.
Original SEC submission ↗NEUROCRINE BIOSCIENCES INC
COMMON · CUSIP 64125C109
Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617
Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.
- Quarter ended
- 2026-09-30
- Filed
- 2026-11-12
- Reported value (USD)
- $594,724,774
- Reported shares
- 4293057
Source units and reporting details
Value as filed: 594724774 USD. Discretion code: DFND. Filing-local manager numbers: 4. Voting authority: sole 3856537, shared 0, none 436520.
Included managers attributed to this row:
- J.P. Morgan Investment Management Inc. · 13F file 028-11937
Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.
Original SEC submission ↗NEUROCRINE BIOSCIENCES INC
COMMON · CUSIP 64125C109
Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617
Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.
- Quarter ended
- 2026-09-30
- Filed
- 2026-11-12
- Reported value (USD)
- $277
- Reported shares
- 2
Source units and reporting details
Value as filed: 277 USD. Discretion code: DFND. Filing-local manager numbers: 6. Voting authority: sole 2, shared 0, none 0.
Included managers attributed to this row:
- J.P. Morgan Securities plc · 13F file 028-12006
Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.
Original SEC submission ↗NEUROCRINE BIOSCIENCES INC
COMMON · CUSIP 64125C109
Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617
Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.
- Quarter ended
- 2026-09-30
- Filed
- 2026-11-12
- Reported value (USD)
- $51,466
- Reported shares
- 372
Source units and reporting details
Value as filed: 51466 USD. Discretion code: DFND. Filing-local manager numbers: 24. Voting authority: sole 372, shared 0, none 0.
Included managers attributed to this row:
- J.P. Morgan SE · 13F file 028-23287
Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.
Original SEC submission ↗NEUROCRINE BIOSCIENCES INC
COMMON · CUSIP 64125C109
Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617
Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.
- Quarter ended
- 2026-09-30
- Filed
- 2026-11-12
- Reported value (USD)
- $16,295,001
- Reported shares
- 117781
Source units and reporting details
Value as filed: 16295001 USD. Discretion code: DFND. Filing-local manager numbers: 16. Voting authority: sole 117781, shared 0, none 0.
Included managers attributed to this row:
- JPMorgan Asset Management (Japan) Ltd · 13F file 028-14958
Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.
Original SEC submission ↗NEUROCRINE BIOSCIENCES INC
COMMON · CUSIP 64125C109
Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617
Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.
- Quarter ended
- 2026-09-30
- Filed
- 2026-11-12
- Reported value (USD)
- $8,501,054
- Reported shares
- 61446
Source units and reporting details
Value as filed: 8501054 USD. Discretion code: DFND. Filing-local manager numbers: 27. Voting authority: sole 61446, shared 0, none 0.
Included managers attributed to this row:
- J.P. MORGAN MANSART MANAGEMENT Ltd · 13F file 028-24651
Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.
Original SEC submission ↗NEUROCRINE BIOSCIENCES INC
COMMON · CUSIP 64125C109
Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617
Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.
- Quarter ended
- 2026-09-30
- Filed
- 2026-11-12
- Reported value (USD)
- $1,065,248
- Reported shares
- 7699
Source units and reporting details
Value as filed: 1065248 USD. Discretion code: DFND. Filing-local manager numbers: 5. Voting authority: sole 0, shared 0, none 7699.
Included managers attributed to this row:
- J.P. Morgan Securities LLC · 13F file 028-11925
Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.
Original SEC submission ↗NEUROCRINE BIOSCIENCES INC
COMMON · CUSIP 64125C109
Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617
Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.
- Quarter ended
- 2026-09-30
- Filed
- 2026-11-12
- Reported value (USD)
- $999,579
- Reported shares
- 7225
Source units and reporting details
Value as filed: 999579 USD. Discretion code: DFND. Filing-local manager numbers: 10. Voting authority: sole 7225, shared 0, none 0.
Included managers attributed to this row:
- JPMorgan Asset Management (Canada) Inc. · 13F file 028-14957
Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.
Original SEC submission ↗NEUROCRINE BIOSCIENCES INC
COMMON · CUSIP 64125C109
Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617
Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.
- Quarter ended
- 2026-09-30
- Filed
- 2026-11-12
- Reported value (USD)
- $3,320
- Reported shares
- 24
Source units and reporting details
Value as filed: 3320 USD. Discretion code: DFND. Filing-local manager numbers: 23. Voting authority: sole 24, shared 0, none 0.
Included managers attributed to this row:
- 55I, LLC · 13F file 028-19649
Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.
Original SEC submission ↗NEUROCRINE BIOSCIENCES INC
COMMON · CUSIP 64125C109
Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617
Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.
- Quarter ended
- 2026-09-30
- Filed
- 2026-11-12
- Reported value (USD)
- $385,305
- Reported shares
- 2785
Source units and reporting details
Value as filed: 385305 USD. Discretion code: DFND. Filing-local manager numbers: 2. Voting authority: sole 2785, shared 0, none 0.
Included managers attributed to this row:
- JPMorgan Chase Bank, N.A. · 13F file 028-00123
Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.
Original SEC submission ↗NEUROCRINE BIOSCIENCES INC
OPTION · CUSIP 64125C909
Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617
Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.
- Quarter ended
- 2026-09-30
- Filed
- 2026-11-12
- Reported value (USD)
- $5,201,960
- Reported shares
- 37600 · Call option
Source units and reporting details
Value as filed: 5201960 USD. Discretion code: DFND. Filing-local manager numbers: 5. Voting authority: sole 37600, shared 0, none 0.
Included managers attributed to this row:
- J.P. Morgan Securities LLC · 13F file 028-11925
Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.
Original SEC submission ↗NEUROCRINE BIOSCIENCES INC
OPTION · CUSIP 64125C959
Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617
Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.
- Quarter ended
- 2026-09-30
- Filed
- 2026-11-12
- Reported value (USD)
- $2,296,610
- Reported shares
- 16600 · Put option
Source units and reporting details
Value as filed: 2296610 USD. Discretion code: DFND. Filing-local manager numbers: 5. Voting authority: sole 16600, shared 0, none 0.
Included managers attributed to this row:
- J.P. Morgan Securities LLC · 13F file 028-11925
Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.
Original SEC submission ↗NEUROGENE INC
COMMON · CUSIP 64135M105
Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617
Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.
- Quarter ended
- 2026-09-30
- Filed
- 2026-11-12
- Reported value (USD)
- $1,436,278
- Reported shares
- 50591
Source units and reporting details
Value as filed: 1436278 USD. Discretion code: DFND. Filing-local manager numbers: 4. Voting authority: sole 45957, shared 0, none 4634.
Included managers attributed to this row:
- J.P. Morgan Investment Management Inc. · 13F file 028-11937
Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.
Original SEC submission ↗NEUROGENE INC
COMMON · CUSIP 64135M105
Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617
Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.
- Quarter ended
- 2026-09-30
- Filed
- 2026-11-12
- Reported value (USD)
- $272,913
- Reported shares
- 9613
Source units and reporting details
Value as filed: 272913 USD. Discretion code: DFND. Filing-local manager numbers: 2. Voting authority: sole 2168, shared 0, none 7445.
Included managers attributed to this row:
- JPMorgan Chase Bank, N.A. · 13F file 028-00123
Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.
Original SEC submission ↗NEUROGENE INC
COMMON · CUSIP 64135M105
Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617
Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.
- Quarter ended
- 2026-09-30
- Filed
- 2026-11-12
- Reported value (USD)
- $49,654
- Reported shares
- 1749
Source units and reporting details
Value as filed: 49654 USD. Discretion code: DFND. Filing-local manager numbers: 6. Voting authority: sole 1749, shared 0, none 0.
Included managers attributed to this row:
- J.P. Morgan Securities plc · 13F file 028-12006
Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.
Original SEC submission ↗NEURONETICS INC
COMMON · CUSIP 64131A105
Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617
Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.
- Quarter ended
- 2026-09-30
- Filed
- 2026-11-12
- Reported value (USD)
- $7,904
- Reported shares
- 3349
Source units and reporting details
Value as filed: 7904 USD. Discretion code: DFND. Filing-local manager numbers: 2. Voting authority: sole 3349, shared 0, none 0.
Included managers attributed to this row:
- JPMorgan Chase Bank, N.A. · 13F file 028-00123
Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.
Original SEC submission ↗NEURONETICS INC
COMMON · CUSIP 64131A105
Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617
Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.
- Quarter ended
- 2026-09-30
- Filed
- 2026-11-12
- Reported value (USD)
- $1,765
- Reported shares
- 748
Source units and reporting details
Value as filed: 1765 USD. Discretion code: DFND. Filing-local manager numbers: 6. Voting authority: sole 748, shared 0, none 0.
Included managers attributed to this row:
- J.P. Morgan Securities plc · 13F file 028-12006
Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.
Original SEC submission ↗NEUROONE MED TECHNOLOGIES CO
COMMON · CUSIP 64130M308
Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617
Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.
- Quarter ended
- 2026-09-30
- Filed
- 2026-11-12
- Reported value (USD)
- $96
- Reported shares
- 88
Source units and reporting details
Value as filed: 96 USD. Discretion code: DFND. Filing-local manager numbers: 5. Voting authority: sole 88, shared 0, none 0.
Included managers attributed to this row:
- J.P. Morgan Securities LLC · 13F file 028-11925
Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.
Original SEC submission ↗NEUROPACE INC
COMMON · CUSIP 641288105
Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617
Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.
- Quarter ended
- 2026-09-30
- Filed
- 2026-11-12
- Reported value (USD)
- $16,129
- Reported shares
- 1157
Source units and reporting details
Value as filed: 16129 USD. Discretion code: DFND. Filing-local manager numbers: 6. Voting authority: sole 1157, shared 0, none 0.
Included managers attributed to this row:
- J.P. Morgan Securities plc · 13F file 028-12006
Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.
Original SEC submission ↗NEUROPACE INC
COMMON · CUSIP 641288105
Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617
Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.
- Quarter ended
- 2026-09-30
- Filed
- 2026-11-12
- Reported value (USD)
- $1,531,685
- Reported shares
- 109877
Source units and reporting details
Value as filed: 1531685 USD. Discretion code: DFND. Filing-local manager numbers: 5. Voting authority: sole 109877, shared 0, none 0.
Included managers attributed to this row:
- J.P. Morgan Securities LLC · 13F file 028-11925
Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.
Original SEC submission ↗NEUROPACE INC
COMMON · CUSIP 641288105
Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617
Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.
- Quarter ended
- 2026-09-30
- Filed
- 2026-11-12
- Reported value (USD)
- $174,975
- Reported shares
- 12552
Source units and reporting details
Value as filed: 174975 USD. Discretion code: DFND. Filing-local manager numbers: 2. Voting authority: sole 0, shared 0, none 12552.
Included managers attributed to this row:
- JPMorgan Chase Bank, N.A. · 13F file 028-00123
Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.
Original SEC submission ↗NEUROPACE INC
COMMON · CUSIP 641288105
Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617
Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.
- Quarter ended
- 2026-09-30
- Filed
- 2026-11-12
- Reported value (USD)
- $23,238
- Reported shares
- 1667
Source units and reporting details
Value as filed: 23238 USD. Discretion code: DFND. Filing-local manager numbers: 5. Voting authority: sole 0, shared 0, none 1667.
Included managers attributed to this row:
- J.P. Morgan Securities LLC · 13F file 028-11925
Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.
Original SEC submission ↗NEUROPACE INC
COMMON · CUSIP 641288105
Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617
Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.
- Quarter ended
- 2026-09-30
- Filed
- 2026-11-12
- Reported value (USD)
- $403,953
- Reported shares
- 28978
Source units and reporting details
Value as filed: 403953 USD. Discretion code: DFND. Filing-local manager numbers: 4. Voting authority: sole 28978, shared 0, none 0.
Included managers attributed to this row:
- J.P. Morgan Investment Management Inc. · 13F file 028-11937
Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.
Original SEC submission ↗NEUROSENSE THERAPEUTICS LTD
COMMON · CUSIP M74240207
Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617
Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.
- Quarter ended
- 2026-09-30
- Filed
- 2026-11-12
- Reported value (USD)
- $5
- Reported shares
- 1
Source units and reporting details
Value as filed: 5 USD. Discretion code: DFND. Filing-local manager numbers: 5. Voting authority: sole 1, shared 0, none 0.
Included managers attributed to this row:
- J.P. Morgan Securities LLC · 13F file 028-11925
Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.
Original SEC submission ↗NEUTRON HOLDINGS INC
COMMON · CUSIP 64125S104
Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617
Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.
- Quarter ended
- 2026-09-30
- Filed
- 2026-11-12
- Reported value (USD)
- $96,264
- Reported shares
- 3386
Source units and reporting details
Value as filed: 96264 USD. Discretion code: DFND. Filing-local manager numbers: 2. Voting authority: sole 0, shared 0, none 3386.
Included managers attributed to this row:
- JPMorgan Chase Bank, N.A. · 13F file 028-00123
Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.
Original SEC submission ↗